Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients

Deveci, K.; Gokakin, A.; Senel, ABDURRAHMAN; Deveci, Hülya; Uslu, A.; Sancakdar, E.

Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients

Deveci K., Gokakin A. K., Senel S., Deveci H., Uslu A. U., Sancakdar E.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.17, sa.2, ss.253-260, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17 Sayı: 2
Basım Tarihi: 2013
Dergi Adı: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.253-260
Anahtar Kelimeler: Familial mediterranean fever, Cystatin C, Amyloidosis
Erciyes Üniversitesi Adresli: Evet

BACKGROUND: The major renal involvement in Familial Mediterranean Fever (FMF) is the occurrence of amyloidosis that primarily affects the kidneys manifested by proteinuria and ending in death from renal failure.

BACKGROUND:

The major renal involvement in Familial Mediterranean Fever (FMF) is the occurrence of amyloidosis that primarily affects the kidneys manifested by proteinuria and ending in death from renal failure.

AIM:

This study aims to investigate whether serum cystatin (cys-C) levels could be used as an early marker of renal involvement in FMF patients.

PATIENTS AND METHODS:

Forty-six patients with FMF during the attack period (AP), and 41 patients with FMF during attack-free periods (AFP), and 11 patients with FMF associated amyloidosis, and 38 healthy controls were enrolled in the study. We determined cys-C levels in the serum of FMF patients and healthy controls.

RESULTS:

Serum cys-C levels were significantly increased in patients with FMF and secondary amyloidosis, and serum cys-C is a more accurate and efficient marker for detecting renal involvement than estimated glomerular filtration rate (e-GFR) in patients with FMF.

CONCLUSIONS:

We propose a cutoff level of the serum cys-C of 876.5 pg/mL for screening renal involvement in patients with FMF, and amyloidosis should be strongly suspected when the serum cys-C reaches 1565.5 pg/mL.